Skip to content
Linkedin
Twitter
Instagram
Vimeo
Youtube
Science
Clinical Trials
ALZHEIMER’S DISEASE
AMYOTROPHIC LATERAL SCLEROSIS (ALS)
FRAGILE X SYNDROME (FXS)
SCHIZOPHRENIA
Media
PRESS RELEASES
IN THE NEWS
Blog
Team
Contact Us
Menu
Science
Clinical Trials
ALZHEIMER’S DISEASE
AMYOTROPHIC LATERAL SCLEROSIS (ALS)
FRAGILE X SYNDROME (FXS)
SCHIZOPHRENIA
Media
PRESS RELEASES
IN THE NEWS
Blog
Team
Contact Us
FDA OKs Phase 1/2 clinical trial of small molecule SPG302 in ALS
Tagged
ALS
